NCT05583890View on ClinicalTrials.gov

A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

August 25, 2022

Primary Completion Date

August 21, 2024

Study Completion Date

August 28, 2024

Conditions
Pancreatic Cancer
Interventions
DEVICE

Continuous glucose monitors

Participants will wear continuous glucose monitors for a 7 day period.

DEVICE

Activity tracker

Participants will wear the activity tracker for a 7 day period.

BEHAVIORAL

Food Diary

Participants will complete a food diary of everything they eat for 7 days.

BEHAVIORAL

Questionnaires

Participants will complete FACT-Hep, DiPcare-Q and health inequality related questions.

Trial Locations (2)

LA1 4YW

Lancaster University, Lancaster

BB2 3HH

East Lancashire Hospitals Trust, Blackburn

All Listed Sponsors
collaborator

East Lancashire Hospitals NHS Trust

OTHER

lead

Lancaster University

OTHER